tbuckley/cabot-search huggingface dataset:
Use of the Z-Plastic Procedure in Ureteroureteral Anastomosis
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Programs in Medical Education Sponsored by Government Agencies
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PLoS Medicine Issue Image | Vol. 4(1) January 2007
Journal: PLoS Medicine (2007)

The top map of the pair shows the global distribution of physicians, with territory drawn in proportion to the number who work there. There were 7.7 million physicians worldwide in 2004 (source: World Health Organization, World Health Report 2006; http://www.worldmapper.org map 219). The bottom map shows each territory of the world with its area scaled in proportion to the number of infants who died in their first week of life there in the year 2000 (3 million worldwide; source: World Health Organization, World Health Report 2005, annex, table 8; http://www.worldmapper.org map 260). This is a global image of the inverse care law found also within most territories as well as between them. Much else influences where physicians are trained and choose to work and where infants are most likely to die in their first seven days. For instance, the number of working midwives is shown in worldmapper map 215 and the number of births attended in map 4; the incidence of diarrhoea in map 233; and the extent of two measures of world poverty and wealth in worldmapper maps 174 and 169 respectively. Image Credit: Images taken from Dorling et al.
Case 20-2014: A 65-Year-Old Man with Dyspnea and Progressively Worsening Lung Disease
Journal: New England Journal of Medicine (2015)

15 per cubic millimeter, rather than 5 per milliliter, and the CD4+ Tcell count mentioned in the third sentence should have been 50 per cubic millimeter, rather than 50 per milliliter.The article is correct at NEJM.org.
Medicine and the universities
Authors: D. R. Goddard
Journal: JAMA (1965)

The theme of this communication is that of the reciprocal relationship of medicine and the universities. The association between the two is an old one which can be traced to the universities of Italy and Paris in the 12th century. The medieval universities had several faculties; the conventional four were law, philosophy, theology, and medicine. However, medical schools per se gradually appeared and probably had their origin from the 17th-century schools of Holland and Scotland; as you have heard from Dr. Corner, the University of Pennsylvania's school had its origin in Edinburgh. By and large, medicine has flowered in the great universities, for they have furnished the environment, the protection, the administration, and, frequently, the funds for its development. In turn, the medical faculties have stimulated the universities and often raised their intellectual levels and standards. Although the proprietary schools that developed during the 19th century in the United States
ABSTRACTS
Authors: H Spaet, T Bothwell, Africa Brittigham, Jacque Caen, J Chatterjea, Pietro Denicota, Ludvik Donner, A Erslev, Philadelphia Fudenberg, San Francisco, Katsuhiro Fukutake, Robert Goldstein, Ira Creen, T Nakao, K Nagano, K Adachi, ! Nakao, I Gasiorowska, K Raczy#{241}-, C Spach, D Streeten, L Kilgore, A Stasch, Ehythrocytes Effect, Reductase Thione, M Koutras, A Hattori, F Schneider, W Ebaugh, H Kirknuin, E Itt, G Brewer, R Powell, A Tarlov, A From, R Schrek
Journal: Blood (1964)
Effect of stopping smoking after unstable angina and myocardial infarction
Authors: L. E Daly, R. Mulcahy, I. M Graham, N. Hickey
Journal: BMJ (1984)

simplistic interpretation to an obviously complex and difficult matter.The absence of randomisation (for which we cannot place blame on the investigators) has merely compounded the problem.In my opinion, whether or not stopping smoking after a coronary attack has a long term survival benefit is still an open question.The diffi- culties in this Irish study exemplify the complexity of the problem.
Deaths Associated With Infant Carriers— United States, 1986-1991
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
Authors: D. Arnold, C.S. Fuchs, J. Tabernero, A. Ohtsu, A.X. Zhu, E.B. Garon, L. Paz-Ares, A.D. Baron, T. Okusaka, T. Yoshino, H.H. Yoon, M. Das, D. Ferry, Y. Zhang, Y. Lin, P. Binder, A. Sashegyi, I. Chau
Journal: Annals of Oncology (2017)
MIKULICZ'S DISEASE
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
University cuts
Authors: J. A Davis
Journal: BMJ (1982)

<h3>Abstract</h3> <b>Objectives:</b> To investigate whether breast feeding is effective for pain relief during venepuncture in term neonates and compare any effect with that of oral glucose combined with a pacifier. <b>Design:</b> Randomised controlled trial. <b>Participants:</b> 180 term newborn infants undergoing venepuncture; 45 in each group. <b>Interventions:</b> During venepuncture infants were either breast fed (group 1), held in their mother9s arms without breast feeding (group 2), given 1 ml of sterile water as placebo (group 3), or given 1 ml of 30% glucose followed by pacifier (group 4). Video recordings of the procedure were assessed by two observers blinded to the purpose of the study. <b>Main outcome measures:</b> Pain related behaviours evaluated with two acute pain rating scales: the Douleur Aiguë Nouveau-né scale (range 0 to 10) and the premature infant pain profile scale (range 0 to 18). <b>Results:</b> Median pain scores (interquartile range) for breast feeding, held in mother9s arms, placebo, and 30% glucose plus pacifier groups were 1 (0–3), 10 (8.5-10), 10 (7.5-10), and 3 (0–5) with the Douleur Aiguë Nouveau-né scale and 4.5 (2.25-8), 13 (10.5-15), 12 (9–13), and 4 (1–6) with the premature infant pain profile scale. Analysis of variance showed significantly different median pain scores (P&lt;0.0001) among the groups. There were significant reductions in both scores for the breast feeding and glucose plus pacifier groups compared with the other two groups (P&lt;0.0001, two tailed Mann-Whitney U tests between groups). The difference in Douleur Aiguë Nouveau-né scores between breast feeding and glucose plus pacifier groups was not significant (P=0.16). <b>Conclusions:</b> Breast feeding effectively reduces response to pain during minor invasive procedure in term neonates. <h3>What is already known on this topic</h3> Current pharmacological treatments are not appropriate for pain relief during minor procedures like venepuncture or heel prick in newborn infants Oral sweet solutions, non-nutritive sucking, and skin to skin contact reduce procedural pain in newborn infants <h3>What this study adds</h3> Breast feeding during a painful procedure effectively reduces the response to pain in newborn infants The analgesic properties of breast feeding are at least as potent as the combination of sweet solutions and a pacifier
DIAGNOSTIC UTILITY OF X-RAYS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PURE FOOD IN WEST VIRGINIA.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Upper Gastrointestinal tumours
Authors: Babu Govmd, /Ish Pun, Jyotsna Fulona, Dinesh Doval, Vasant Pai, Ashok Vaid, Binh Nguyen, Sachin Kapil, P Prabhakaran, Joseph Schulz, Jim Cassidv, ' Twelves, J Bernhard, A Lowy, R Maibach, Llaria Panzini, Lorenzo Gianni, Davide Tassinari, Barbara Venturing, Emanuela Nocelli, Giuhana Drudi, Valentina Arcangeli, Giuseppe Pasini, Francesca Fochessati, C Pozzo, C Peschel, T Popiela, V Gorbunova, E Zuber, D Di-Betta, M Alakl, C Jacques, C Barone, Enc Van Cutsem, J Ayani, S Tjulandin, V Mniseyenko, F Cabral, A Majlis, A Blattmann, C Garay
Journal: Annals of Oncology (2000)
Novel mutational and pathway signatures in relapsed/refractory colorectal cancer patients.
Authors: Benny Johnson, Laurence Cooke, Daruka Mahadevan
Journal: Journal of Clinical Oncology (2016)

e15002 Background: In the management of metastatic colorectal cancer (mCRC), all RAS (KRAS, NRAS) and BRAF V600E mutation status guides therapeutic options and identify a unique cohort of patients (pts) with a more aggressive clinical course. We hypothesized that relapsed/refractory CRC pts develop unique mutational signatures that guide standard and targeted therapy but also predict for therapeutic response, identify novel driver mutations and highlight key signaling pathways for clinical decision making. Methods: Relapsed/refractory mCRC pts (N = 32) were molecularly profiled by NGS Caris Molecular Intelligence (IHC, FISH/CISH, NGS) and/or Foundation One (NGS, copy number). Samples were annotated by histology, primary and/or metastatic site, biopsy location, gene mutation, domain, topology, and mutation count. Web-based bioinformatics tools (Enrichr) were utilized to analyze mutational profiles, identifying pathway-networks. Results: Pts included progressed on fluoropyrimidines, oxaliplatin, irinotecan, bevacizumab, cetuximab and/or panitumumab.Most common histology was adenocarcinoma followed by squamous cell carcinoma (colon N = 29; rectal N = 3).TP53 was the most common mutation followed by APC, KRAS, PIK3CA, BRAF, SMAD4, SPTA1, FAT1, PDGFRA, ATM, ROS1, ALK, CDKN2A, FBXW7, TGFBR2, NOTCH1 and HER3. Pts had on average > 5 unique gene mutations. 5 pts were MSI-H. High mutational burden was not predictive for PD-1 (5 pts) or PD-L1 (1 pt) positivity.The most common activated signaling pathways were: ERRB2/HER2, FGFR, p38 activation through BRAF-MEK cascade via RIT and RIN, ARMS-mediated activation of MAPK cascade, and VEGFR2. Conclusions: Dominant oncogene mutations do not always equate with oncogenic dependence, therefore understanding the pathologic interactome in each patient is important to both identification of clinically relevant targets and choosing the next best therapy. Mutational signatures derived from corresponding ‘pathway-networks’ represent a meaningful tool to 1). Evaluate functional investigation in the laboratory, 2). Predict response to drug therapy, and 3). Guide rational drug combinations in relapsed/refractory mCRC pts entering targeted and immune checkpoint trials.
THINKING DISORDER IN NEUROSES
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Hantaviruses, Etiologic Agents Of Hemorrhagic Fever With Renal Syndrome: A Possible Cause Of Hypertension And Chronic Renal Disease In The United
Authors: J. LeDuc
Journal: Annual Review of Public Health (1992)

In recent decades, there has been remarkable growth in scientific research examining the multiple ways in which racism can adversely affect health. This interest has been driven in part by the striking persistence of racial/ethnic inequities in health and ...Read More
Factors affecting quality of life in patients with vitiligo: a nationwide study
Authors: J.M. Bae, S.C. Lee, T.H. Kim, S.D. Yeom, J.H. Shin, W.J. Lee, M.‐H. Lee, A.‐Y. Lee, K.H. Kim, M.B. Kim, C.J. Park, S.H. Lee, D.H. Kim, H.J. Lee, D.Y. Lee, C.W. Choi, Y.C. Kim, H.Y. Kang, S. Haw, Y.B. Lee, S.J. Yun, S.‐K. Yun, S.P. Hong, Y. Lee, H.J. Kim, G.S. Choi
Journal: British Journal of Dermatology (2018)

In vitiligo, areas of skin lose their colour and become completely white. These white areas, which are often irregular like islands on a map, usually stand out against the normal skin around them, and are very obvious in individuals with a naturally pigmented (brown or black) skin, or in white‐skinned people with a tan. People with vitiligo can become very embarrassed and withdrawn, not wanting to go out or to meet people; as a result, the quality of their day‐to‐day life can suffer. Vitiligo affects between 0.5% and 2% of the population and treatment does not work very well. This study from South Korea looked at what factors to do with vitiligo most affected patients’ quality of life. It was a large study involving more than 1,100 adults from 21 different hospitals. Patients filled in a detailed questionnaire called the Skindex‐29 questionnaire and members of the study team examined the patients’ skin. From the questionnaire results, what concerned patients most were whether the vitiligo was going to get worse and whether it was a serious condition. They were also concerned about how loved ones felt about it, and over half the patients felt depressed about their condition. Involvement of large areas of the body, or areas of the body that other people could easily see, particularly affected quality of life. Vitiligo is far from just a cosmetic problem: over a third of patients were affected emotionally even if the areas of vitiligo were normally covered up.
The March of Medicine
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A 47-Year-Old Woman With Ductal Carcinoma In Situ of the Breast
Authors: Julie Kaufman
Journal: JAMA (1996)

<h3>To the Editor.</h3> —The Clinical Crossroads article by Dr Morrow<sup>1</sup>was clinically informative regarding treatment options and outcomes for breast ductal carcinoma in situ (DCIS). It would have been useful if the discussion also included the mammographic evaluation that led to the biopsy. Primary care physicians who routinely advise their patients to have screening mammography not infrequently receive a reading with a recommendation for a 6-month follow-up examination. Mrs Y may have saved herself from such follow-up by seeking a second opinion—is it appropriate to wait 6 months for follow-up? The American College of Radiology has suggested a standardized nomenclature for mammography and, in effect, has categorized the level of suspicion for malignancy.<sup>2</sup>Why did the second group of physicians described in the article recommend biopsy when the original radiologist recommended a 6-month reexamination? Indeed, for indeterminant or probably benign abnormalities, the latter approach is expected to yield